A0A0D9QZU0 (A0A0D9QZU0_CHLSB) Chlorocebus sabaeus (Green monkey) (Cercopithecus sabaeus)

Hypoxia inducible factor 1 subunit alpha inhibitor UniProtKBInterProSTRINGInteractive Modelling

349 aa; Sequence (Fasta) ; 9 identical sequences: Homo sapiens: Q9NWT6; Mandrillus leucophaeus: A0A2K6AAA4; Theropithecus gelada: A0A8D2K4B2; Macaca mulatta: H9ZB15, A0A8J8XH10; Macaca fascicularis: G7PDR7; Cercocebus atys: A0A2K5KSK4; Piliocolobus tephrosceles: A0A8C9I1L9; Colobus angolensis palliatus: A0A2K5IL80

Available Structures

59 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPA1 (313-339)
6hc8
 Heteromer
O75762; Q9NWT6; 		1-349
2×ZN; 2×OGA; 2×SO4; 6×GOL;
Assess
FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), NOG AND ASP-SUBSTRATE PEPTIDE (20-…
2xum
 Heteromer
Q9NWT6; 		1-349
2×ZN; 2×OGA; 6×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-LEU PEPTIDE (20-MER)
4b7e
 Heteromer
Q9NWT6; 		1-349
2×ZN; 2×OGA; 10×SO4; 8×GOL;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-ethyl-2-oxoglutarate, AND CONSENSUS ANKYRIN…
7a1o
 Heteromer
Q9NWT6; 		3-349
2×ZN; 8×SO4; 2×QVT;
Assess
Crystal structure of human FIH D201E variant in complex with Zn, alpha-ketoglutarate, and HIF1 alph…
5jwp
 Heteromer
Q16665; Q9NWT6; 		8-349
2×AKG; 2×GOL; 2×ZN; 8×SO4;
Assess
Factor Inhibiting HIF-1 Alpha D201A Mutant in Complex with FE(II), Alpha-Ketoglutarate and HIF-1 Al…
2ilm
 Heteromer
Q16665; Q9NWT6; 		8-349
2×FE2; 4×SO4; 2×BCT; 2×AKG; 6×GOL;
Assess
Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1930-1949) peptide
3p3n
 Heteromer
Q01705; Q9NWT6; 		9-349
2×FE2; 4×SO4; 2×AKG; 8×GOL;
Assess
Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1997-2016) peptide
3p3p
 Heteromer
Q01705; Q9NWT6; 		9-349
2×FE2; 2×AKG; 4×SO4; 6×GOL;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (220-246)
6ha6
 Heteromer
Q8NET8; Q9NWT6; 		10-349
2×OGA; 8×SO4; 6×GOL; 2×ZN;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH TANKYRASE-2 (TNKS2) FRAGMENT PEPTIDE (21-MER)
2y0i
 Heteromer
Q9H2K2; Q9NWT6; 		11-349
2×FE2; 2×AKG; 6×SO4; 4×GOL;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-(carboxycarbonyl)cyclopentane-1-carboxylic …
7a1q
 Heteromer
Q9NWT6; 		12-349
2×ZN; 6×SO4; 2×QVQ;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-propyl-2-oxoglutarate, AND CONSENSUS ANKYRI…
7a1p
 Heteromer
Q9NWT6; 		12-349
2×ZN; 6×SO4; 2×QW2;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (229-255)
6h9j
 Heteromer
Q8NET8; Q9NWT6; 		12-349
2×OGA; 6×GOL; 8×SO4; 2×ZN;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP2 (970-992)
6hkp
 Heteromer
Q13625; Q9NWT6; 		12-349
12×SO4; 10×GOL; 2×OGA; 2×ZN;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP1(932-954)
6hl5
 Heteromer
Q96KQ4; Q9NWT6; 		12-349
8×GOL; 8×SO4; 2×ZN; 2×OGA;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and iASPP(670-693)
6hl6
 Heteromer
Q8WUF5; Q9NWT6; 		15-349
10×GOL; 6×SO4; 2×ZN; 2×OGA;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND TANKYRASE-2 (TNK…
7a1s
 Heteromer
Q9H2K2; Q9NWT6; 		15-349
8×SO4; 1×ROQ; 1×ZN;
Assess
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide
1h2k
 Heteromer
Q16665; Q9NWT6; 		15-349
2×FE2; 2×OGA; 4×SO4;
Assess
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide
1h2l
 Heteromer
Q16665; Q9NWT6; 		15-349
2×FE2; 2×AKG; 4×SO4;
Assess
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide
1h2m
 Heteromer
Q16665; Q9NWT6; 		15-349
2×ZN; 2×OGA; 4×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND CONSENSUS ANKYRI…
7a1n
 Heteromer
Q9NWT6; 		20-349
9×SO4; 1×ZN; 1×ROQ;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH R-2-HYDROXYGLUTARATE
2yc0
homo-2-mer1-349
2×FE2; 2×2HG; 6×GOL; 8×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH S-2-HYDROXYGLUTARATE
2yde
homo-2-mer1-349
2×FE; 4×S2G; 4×GOL; 8×SO4;
Assess
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)3-hydroxy-Leu pept…
6ruj
homo-2-mer1-349
2×ZN; 2×OGA; 6×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID
2w0x
homo-2-mer8-349
2×FE2; 2×PD2; 6×SO4; 2×GOL;
Assess
Crystal Structure of Factor Inhibiting HIF-1 Alpha Complexed with Inhibitor
3od4
homo-2-mer8-349
2×ZN; 2×8XQ; 6×SO4; 8×GOL;
Assess
Structure of Factor Inhibiting HIF (FIH) in complex with Fe, NO, and NOG
4z1v
homo-2-mer9-349
2×OGA; 2×NO; 2×PEG; 2×FE; 10×SO4;
Assess
Factor Inhibiting HIF D201E in Complex with Fe, and Alpha-Ketoglutarate
5jwk
homo-2-mer9-349
2×AKG; 2×PEG; 2×FE2; 4×SO4;
Assess
Factor Inhibiting HIF D201E in Complex with Zn, and Alpha-Ketoglutarate
5jwl
homo-2-mer9-349
2×AKG; 2×PEG; 2×ZN; 4×SO4;
Assess
Factor Inhibiting HIF in Complex with Fe, and Alpha-Ketoglutarate
4z2w
homo-2-mer9-349
2×AKG; 2×PEG; 2×FE; 10×SO4;
Assess
Factor inhibiting HIF-1 alpha D201G mutant in complex with ZN(II), alpha-ketoglutarate and HIF-1 al…
3d8c
homo-2-mer11-349
2×ZN; 4×SO4; 2×AKG; 2×GOL;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc and Vadadustat
5opc
homo-2-mer11-349
10×SO4; 2×ZN; 10×GOL; 2×A1Z;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH DAMINOZIDE
4ai8
homo-2-mer11-349
10×SO4; 6×GOL; 2×DZA; 2×ZN;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH 8-HYDROXYQUINOLINE-5- CARBOXYLIC ACID
4bio
homo-2-mer11-349
2×FE; 2×8XQ; 10×SO4; 8×GOL;
Assess
Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((1-(phenylsul…
8k73
homo-2-mer12-349
14×SO4; 14×GOL; 2×ZN; 2×VK6;
Assess
Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((2-((naphthal…
8k71
homo-2-mer12-349
2×ZN; 2×VIZ; 16×SO4; 14×GOL;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-SER PEPTIDE (20-MER)
4b7k
homo-2-mer12-349
2×ZN; 2×OGA; 8×SO4;
Assess
Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((3-(phenylsul…
8k72
homo-2-mer12-349
20×SO4; 6×GOL; 2×ZN; 2×VJF;
Assess
Dimeric structure of FIH (Factor inhibiting HIF)
1iz3
homo-2-mer12-349
2×SO4;
Assess
Human Factor Inhibiting HIF (FIH1)
1mze
homo-2-mer13-349
2×FE2; 2×TAR;
Assess
Human Factor inhibiting HIF (FIH1) in Complex with 2-oxoglutarate
1mzf
homo-2-mer13-349
2×FE2; 2×AKG;
Assess
Factor inhibiting HIF-1 alpha in complex with N-(carboxycarbonyl)-D-phenylalanine
1yci
homo-2-mer14-349
2×FE2; 6×SO4; 4×NDF;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-(3-phenylpropyl)-2-oxoglutarate
7a1j
homo-2-mer15-349
2×ZN; 10×SO4; 2×QVN;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-((9,9-dimethyl-9H-fluoren-2-yl)methyl)-2…
7a1k
homo-2-mer15-349
2×ZN; 2×QVZ; 8×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-propyl-2-oxoglutarate
7a1m
homo-2-mer15-349
2×ZN; 2×QVW; 6×SO4;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc and Molidustat
5op8
homo-2-mer15-349
2×ZN; 2×A1H; 6×SO4; 4×GOL;
Assess
FACTOR INHIBITING HIF-1 ALPHA WITH N,3-dihydroxybenzamide
2wa4
homo-2-mer15-349
2×FE2; 4×069; 2×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3-hydroxyphenyl)-2-oxoacetic acid
2wa3
homo-2-mer15-349
2×FE2; 2×A29;
Assess
Factor inhibiting HIF-1 alpha in complex with 8-hydroxyquinoline
3kcy
homo-2-mer15-349
2×FE2; 4×SO4; 2×HQY;
Assess
Factor inhibiting HIF-1 alpha in complex with Clioquinol
3kcx
homo-2-mer15-349
2×FE2; 4×SO4; 6×GOL; 2×CQL;
Assess
Factor Inhibiting HIF-1 alpha
1h2n
homo-2-mer15-349
2×FE2; 2×AKG; 6×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA with succinate
2cgn
monomer3-349
1×FE; 1×SIN; 4×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA with fumarate
2cgo
monomer8-349
1×FE; 1×FUM; 4×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA in complex with (5-(3-(3-chlorophenyl)isoxazol-5-yl)-3-hydroxypicolin…
8ii0
monomer9-349
1×P5I; 2×GOL; 1×ZN; 8×SO4;
Assess
FACTOR INHIBITING HIF-1 ALPHA in complex with (5-(1-(3-(4-chlorophenyl)propyl)-1H-1,2,3-triazol-4-y…
8ihz
monomer9-349
14×SO4; 1×ZN; 1×P1X;
Assess
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-methyl-2-oxoglutarate
7a1l
monomer15-349
1×ROQ; 1×ZN; 4×SO4;
Assess
Factor Inhibiting HIF (FIH) in complex with zinc and GSK128863
5op6
monomer15-349
1×ZN; 2×SO4; 1×A0W; 1×GOL;
Assess
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)allyl-GLY peptide
4nr1
monomer15-349
1×ZN; 1×OGA; 3×SO4;
Assess
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)LEU peptide
4jaa
monomer22-349
1×ZN; 1×OGA; 2×SO4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5jwk.1.Bhomo-2-mer0.919-349
99.71
Assess